Patent: 7,056,529
✉ Email this page to a colleague
Summary for Patent: 7,056,529
Title: | Direct cellular energy delivery system |
Abstract: | A vesicle comprises ATP and a phospholipid which is a stable vesicle former. The vesicle has a fusion rate of at least 20 vesicle fusions/second. |
Inventor(s): | Ehringer; William D. (Charlestown, IN), Chien; Sufan (Floyd Knobbs, IN) |
Assignee: | University of Louisville Research Foundation, Inc. (Louisville, KY) |
Application Number: | 10/397,048 |
Patent Claims: | see list of patent claims |
Details for Patent 7,056,529
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | REGRANEX | becaplermin | Gel | 103691 | 12/16/1997 | ⤷ Try a Trial | 2022-05-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |